Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma
Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma
Whole genome sequencing reveals underlying genetics of multiple myeloma
Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12
Advances in multiple myeloma from ASH 2012
Expert overview of hot news in lymphoma from ASH 2012 (2/2)
Multiple myeloma advances for the future suggested by phase I clinical research
Pre-Implantation genetic diagnosis
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study
Investigation of Ki67 biomarker
Results of a randomised phase 2 study of PD 0332991
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)